Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006.
about
New treatments compared to established treatments in randomized trialsComparison of protocols and registry entries to published reports for randomised controlled trialsAssociation of trial registration with the results and conclusions of published trials of new oncology drugsOptimism bias leads to inconclusive results-an empirical study.Predicting harms and benefits in translational trials: ethics, evidence, and uncertainty.A social network analysis of treatment discoveries in cancer.When is it rational to participate in a clinical trial? A game theory approach incorporating trust, regret and guiltTreatment success in cancer: industry compared to publicly sponsored randomized controlled trials.Phase III clinical trial development: a process of chutes and laddersTreatment success in pragmatic randomised controlled trials: a review of trials funded by the UK Health Technology Assessment programme.Description of the protocols for randomized controlled trials on cancer drugs conducted in Spain (1999-2003).Uncertainty and equipoise: at interplay between epistemology, decision making and ethicsA Model of Cancer Clinical Trial Decision-making Informed by African-American Cancer Patients.Recruitment of ethnic minorities into cancer clinical trials: experience from the front linesImplementation of AMNOG: An industry perspectiveDo we want more cancer patients on clinical trials if so, what are the barriers to greater accrual.The impact of insurance on access to cancer clinical trials at a comprehensive cancer centerThe Scientific Impact of Positive and Negative Phase 3 Cancer Clinical Trials.Evolution of the randomized controlled trial in oncology over three decades.Methodological approach to determine minor, considerable, and major treatment effects in the early benefit assessment of new drugsThe paradox of equipoise: the principle that drives and limits therapeutic discoveries in clinical research.Taking the long view: how to design a series of Phase III trials to maximize cumulative therapeutic benefit.The misguided ethics of crossover trials.A Comprehensive Program for the Enhancement of Accrual to Clinical Trials.Use of Bayesian Decision Analysis to Minimize Harm in Patient-Centered Randomized Clinical Trials in Oncology.New insights into the evaluation of randomized controlled trials for rare diseases over a long-term research horizon: a simulation study.Development and Evaluation of an Approach to Using Value of Information Analyses for Real-Time Prioritization Decisions Within SWOG, a Large Cancer Clinical Trials Cooperative Group.A framework to assess the value of subgroup analyses when the overall treatment effect is significant.A framework to assess the value of application of formal criteria to check clinical relevance in RCTs as part of a benefit assessment strategy.Addressing clinical trials: can the multidisciplinary Tumor Board improve participation? A study from an academic women's cancer program.A randomized two-stage design for phase II clinical trials based on a Bayesian predictive approach.Unblinding following trial participation: qualitative study of participants' perspectives.Research ethics. Global research integrity training.A new statistical decision rule for single-arm phase II oncology trials.Triangulating on success: innovation, public health, medical care, and cause-specific US mortality rates over a half century (1950-2000).Better to be in The Placebo Arm for Trials of Neurological Therapies?
P2860
Q24198868-EDA03E18-E135-4FE7-AC45-30086F8B32A4Q24235035-80F138F6-E91C-4692-A5D0-9BE3849B31B9Q24288921-68006551-7112-4D6A-BFED-3A751596792DQ30426685-320CE07F-3A46-4B11-A992-4E8183D9BBE0Q33851241-7FC90DC7-3CCC-49BF-A695-7FFA2473063EQ33862463-458784EC-CD50-4D9C-893A-A9A1FD495901Q34314845-2D6B4B99-0909-4FF9-9D4E-23CC3F83A776Q34650505-7D7F1C95-B393-409B-A856-ED62C133CEDEQ34680489-E02003BF-B164-4BAA-B2C5-FDCDD4334A05Q35042324-88DA9ABA-851D-4EAB-B824-D4A7DA281AD2Q35043881-411F3639-8576-414C-AC26-BC82940BBBD8Q35242940-7BA097C0-9622-47F0-9E19-447FFE445FE9Q35572309-143B9ECF-34E8-4DD2-B098-7D909EEC99E7Q36287934-65334AA8-DE64-427E-93B2-2729E2CF98CFQ36533079-64301A62-5526-4961-A834-9FA100E7C68AQ36724414-0B58DDD2-0A14-422E-84F8-571A71E21F9BQ37023806-C6994690-48F4-4ACA-96AF-96720E00DC1EQ37095602-07E8F986-36FB-4836-9A1D-AD6364F3EF5CQ37117089-FC5E8DD7-D64C-4303-8034-9F7BA2B2237EQ37279176-4113F013-891A-4A63-91EE-CE3E05F678C0Q37436702-4B9506D8-3A61-4103-A0C9-8666A5462EA1Q37522787-2022F52C-C040-4083-BCD9-554C2EB63680Q37694970-29F0F83D-FD07-47C9-9349-C25095BDCEB7Q38383468-8A885C9A-1DBC-4626-BFE9-E72BEDC73DDFQ38729003-EBA58E48-CE9C-431B-A0EC-CC3AA791F44AQ38888445-9A8FA127-049B-4ABE-9D97-4AE010287159Q38890570-55DF6025-23B1-4510-8D7A-E021B7BFDE96Q38999372-47489218-8688-4E8D-89D7-A85E9ABBBDCEQ41052592-8FEA7FE6-44D8-4DED-AF8B-906460850C7DQ41334502-1917ECED-EB19-4B3E-B529-0DE3930AF60CQ41643154-937A11A1-B233-4026-BC92-4CFD59DDB354Q43992708-53EEE25E-9BB8-4635-9C40-D4A0EA0182A4Q48250270-15221F5B-2573-42CA-8EAF-7A7AA28C3B92Q51392647-1B0683A5-D40B-4251-85A0-F68B65D09E79Q53083519-0E7AFC39-5B71-4415-A64C-541B7236314AQ55642155-91E53DFB-34E8-45FC-94AB-72134F69456E
P2860
Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment success in cancer: n ...... oncology groups, 1955 to 2006.
@en
Treatment success in cancer: n ...... oncology groups, 1955 to 2006.
@nl
type
label
Treatment success in cancer: n ...... oncology groups, 1955 to 2006.
@en
Treatment success in cancer: n ...... oncology groups, 1955 to 2006.
@nl
prefLabel
Treatment success in cancer: n ...... oncology groups, 1955 to 2006.
@en
Treatment success in cancer: n ...... oncology groups, 1955 to 2006.
@nl
P2093
P2860
P1476
Treatment success in cancer: n ...... oncology groups, 1955 to 2006.
@en
P2093
Ambuj Kumar
Charles L Bennett
Gerold Bepler
Heloisa P Soares
Mike Clarke
P2860
P304
P356
10.1001/ARCHINTE.168.6.632
P407
P577
2008-03-01T00:00:00Z